|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 13 October 2021, 9:45. The announcement is not marked as price sensitive, and is 26 page(s) in length and 2.44MB in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| AGM Presentation | 13 October 2021, 9:45 |
| Depression Patent for Orotate Approved by US Patent Office | 8 October 2021, 16:05 |
| Nanocelle Issued Notice of Allowance by US Patent Office | 6 October 2021, 9:22 |
| Proposed issue of securities - MDC | 14 September 2021, 16:04 |
You must be logged in to post a reply.
Medlab Clinical 